Piper Jaffray Raises Price Target as Abiomed's (ABMD) Results Fall In-line with Preliminary Release

Go back to Piper Jaffray Raises Price Target as Abiomed's (ABMD) Results Fall In-line with Preliminary Release

Abiomed (ABMD) Tops Q3 EPS by 8c

February 4, 2016 7:02 AM EST

Abiomed (NASDAQ: ABMD) reported Q3 EPS of $0.23, $0.08 better than the analyst estimate of $0.15. Revenue for the quarter came in at $85.8 million versus the consensus estimate of $80.04 million.

For earnings history and earnings-related data on Abiomed (ABMD) click here.

... More

Trading Radar for 2/4: Cigna (CI), ConocoPhillips (COP), LinkedIn (LNKD), Occidental (OXY), News Corp. (NWSA) Report

February 3, 2016 2:27 PM EST

The Trading Radar highlights key earnings and economic announcements for the next trading session:

Before Markets Open:
Economics:
8:30am EST

Initial Claims - Street sees 275kContinuing Claims - Street sees 2.253MProductivity: Prelim. - Street sees (1.7%)Unit Labor Costs: Prelim. - Street sees 3.8%

Earnings:

Abiomed (Nasdaq: ABMD) - consensus EPS $0.15
AmerisourceBergen (NYSE: ABC) - consensus EPS $1.25
Arrow Electronics (NYSE: ARW) - consensus EPS $1.83
Asbury Automotive Group... More